Lipid nanoparticle formulation of niclosamide (nano NCM) effectively inhibits SARS-CoV-2 replication in vitro

Guankui Wang; Hanmant Gaikwad; Mary McCarthy; Mercedes Gonzalez-Juarrero; Yue Li; Michael Armstrong; Nichole Reisdorph; Thomas Morrison; Dmitri Simberg

doi:10.33218/001c.18813

Loading [Contrib]/a11y/accessibility-menu.js

Wang, Guankui, Hanmant Gaikwad, Mary McCarthy, Mercedes Gonzalez-Juarrero, Yue Li, Michael Armstrong, Nichole Reisdorph, Thomas Morrison, and Dmitri Simberg. 2021. “Lipid Nanoparticle Formulation of Niclosamide (Nano NCM) Effectively Inhibits SARS-CoV-2 Replication in Vitro.” Precision Nanomedicine 4 (1): 724–37. https://doi.org/10.33218/001c.18813.

View more stats